Literature DB >> 20966120

Hyperfiltration affects accuracy of creatinine eGFR measurement.

Shih-Han S Huang1, Ajay P Sharma, Abeer Yasin, Robert M Lindsay, William F Clark, Guido Filler.   

Abstract

BACKGROUND AND OBJECTIVES: Surrogate markers such as creatinine, cystatin C (CysC), and beta trace protein (BTP) have been used to estimate GFR (eGFR). The accuracy of eGFR may be altered with hyperfiltration and differences in filtration fraction (FF). It is hypothesized that the accuracy of creatinine for eGFR may be affected by hyperfiltration and different effective renal plasma flow (ERPF). DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A total of 127 pediatric patients with various renal diseases underwent simultaneous measurements of GFR using 51Cr-EDTA renal scan and ERPF (131I-hippurate clearance) to calculate the FF (FF=GFR/ERPF). The eGFRs were calculated using the commonly used Schwartz (creatinine), Filler (CysC), and Benlamri (BTP) formulas. Agreement of the eGFRs with the measured isotope GFRs was assessed by Bland-Altman plots. Correlation analysis was performed using nonparametric tests to compare FF with eGFR-GFR.
RESULTS: The 127 children at a median age (with 25th percentile, 75th percentile) of 11.9 (8.5, 14.9) years had a mean 51Cr EDTA-GFR of 100.6±32.1 ml/min per 1.73 m2 and a median 131I-hippurate clearance (ERPF) of 588 (398,739) ml/min per 1.73 m2. Mean FF was 17.7±4.5% with no correlation between the FF and the error (eGFR-GFR) for CysC and BTP eGFR, whereas there was a significant negative correlation between the error for Schwartz eGFR and FF.
CONCLUSIONS: There is a significant negative correlation between the error for the Schwartz eGFR and the FF. CysC and BTP are not affected by differences in FF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20966120      PMCID: PMC3052216          DOI: 10.2215/CJN.02760310

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  34 in total

1.  Estimation of glomerular filtration rate from plasma clearance of 51-chromium edetic acid.

Authors:  C Chantler; T M Barratt
Journal:  Arch Dis Child       Date:  1972-08       Impact factor: 3.791

2.  Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults.

Authors:  E Vinge; B Lindergård; P Nilsson-Ehle; A Grubb
Journal:  Scand J Clin Lab Invest       Date:  1999-12       Impact factor: 1.713

3.  Beta-trace protein, cystatin C, beta(2)-microglobulin, and creatinine compared for detecting impaired glomerular filtration rates in children.

Authors:  Guido Filler; Friedrich Priem; Nathalie Lepage; Pranav Sinha; Ilka Vollmer; Heather Clark; Erin Keely; Mary Matzinger; Ayub Akbari; Harald Althaus; Klaus Jung
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

4.  Validation of plasma clearance of 51Cr-EDTA in adult renal transplant recipients: comparison with inulin renal clearance.

Authors:  Flávia Silva Reis Medeiros; Marcelo T Sapienza; Elisângela S Prado; Fabiana Agena; Maria H M Shimizu; Francine B C Lemos; Carlos A Buchpiguel; Luiz E Ianhez; Elias David-Neto
Journal:  Transpl Int       Date:  2008-12-03       Impact factor: 3.782

5.  Development of a beta-trace protein based formula for estimation of glomerular filtration rate.

Authors:  Amina Benlamri; Renisha Nadarajah; Abeer Yasin; Nathalie Lepage; Ajay P Sharma; Guido Filler
Journal:  Pediatr Nephrol       Date:  2009-12-01       Impact factor: 3.714

6.  Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

Authors:  Vikas R Dharnidharka; Charles Kwon; Gary Stevens
Journal:  Am J Kidney Dis       Date:  2002-08       Impact factor: 8.860

Review 7.  How to monitor renal function in pediatric solid organ transplant recipients.

Authors:  Guido Filler; Ajay P Sharma
Journal:  Pediatr Transplant       Date:  2007-12-27

8.  Evaluation of renal graft haemodynamia by 51Cr-EDTA and o-[131I]iodohippurate: its use in the early diagnosis of glomerular hyperfiltration.

Authors:  M Estorch; A Tembl; R Antonijoan; A Hernandez; C Mari; A Flotats; V Camacho; R Sola; M Barbanoj; I Carrio
Journal:  Nucl Med Commun       Date:  2003-06       Impact factor: 1.690

9.  Should the Schwartz formula for estimation of GFR be replaced by cystatin C formula?

Authors:  Guido Filler; Nathalie Lepage
Journal:  Pediatr Nephrol       Date:  2003-08-13       Impact factor: 3.714

Review 10.  Cystatin C--properties and use as diagnostic marker.

Authors:  A O Grubb
Journal:  Adv Clin Chem       Date:  2000       Impact factor: 5.394

View more
  23 in total

Review 1.  Glomerular Hyperfiltration in Diabetes: Mechanisms, Clinical Significance, and Treatment.

Authors:  Lennart Tonneijck; Marcel H A Muskiet; Mark M Smits; Erik J van Bommel; Hiddo J L Heerspink; Daniël H van Raalte; Jaap A Joles
Journal:  J Am Soc Nephrol       Date:  2017-01-31       Impact factor: 10.121

2.  A step forward towards accurately assessing glomerular filtration rate in newborns.

Authors:  Guido Filler
Journal:  Pediatr Nephrol       Date:  2015-05-05       Impact factor: 3.714

Review 3.  A systematic review of glomerular hyperfiltration assessment and definition in the medical literature.

Authors:  Francois Cachat; Christophe Combescure; Michel Cauderay; Eric Girardin; Hassib Chehade
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-07       Impact factor: 8.237

Review 4.  Methods of assessing renal function.

Authors:  Guido Filler; Abeer Yasin; Mara Medeiros
Journal:  Pediatr Nephrol       Date:  2013-02-17       Impact factor: 3.714

Review 5.  Glomerular hyperfiltration: definitions, mechanisms and clinical implications.

Authors:  Imed Helal; Godela M Fick-Brosnahan; Berenice Reed-Gitomer; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2012-02-21       Impact factor: 28.314

Review 6.  Update on Estimation of Kidney Function in Diabetic Kidney Disease.

Authors:  Petter Bjornstad; David Z Cherney; David M Maahs
Journal:  Curr Diab Rep       Date:  2015-09       Impact factor: 4.810

7.  Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.

Authors:  Charles T Quinn; Santosh L Saraf; Victor R Gordeuk; Courtney D Fitzhugh; Susan E Creary; Prasad Bodas; Alex George; Ashok B Raj; Alecia C Nero; Catherine E Terrell; Lisa McCord; Adam Lane; Hans C Ackerman; Yu Yang; Omar Niss; Michael D Taylor; Prasad Devarajan; Punam Malik
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

8.  Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.

Authors:  Imed Helal; Berenice Reed; Kim McFann; Xiang-Dong Yan; Godela M Fick-Brosnahan; Melissa Cadnapaphornchai; Robert W Schrier
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-08       Impact factor: 8.237

9.  Estimation of GFR using β-trace protein in children.

Authors:  Samantha H Witzel; Shih-Han S Huang; Branko Braam; Guido Filler
Journal:  Clin J Am Soc Nephrol       Date:  2014-12-26       Impact factor: 8.237

Review 10.  Cystatin C: a step forward in assessing kidney function and cardiovascular risk.

Authors:  Johan Lassus; Veli-Pekka Harjola
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.